Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T17:29:49.966Z Has data issue: false hasContentIssue false

Gentamicin-Susceptible or Gentamicin-Resistant Methicillin-Resistant Staphylococcus aureus A Case-Case Study

Published online by Cambridge University Press:  21 June 2016

Jérôme Robert*
Affiliation:
Bactériologie-Hygiène, Faculté de Médecine Pierre et Marie Curie–Paris 6, Site Pitié-Salpétriêre, Paris, France
Roland Bismuth
Affiliation:
Bactériologie-Hygiène, Faculté de Médecine Pierre et Marie Curie–Paris 6, Site Pitié-Salpétriêre, Paris, France
Nadine Lemaitre
Affiliation:
Bactériologie-Hygiène, Faculté de Médecine Pierre et Marie Curie–Paris 6, Site Pitié-Salpétriêre, Paris, France
Vincent Jarlier
Affiliation:
Bactériologie-Hygiène, Faculté de Médecine Pierre et Marie Curie–Paris 6, Site Pitié-Salpétriêre, Paris, France
*
Laboratoire de Bactériologie-Hygiène, Faculté de Médecine Pitié-Salpétriêre, Université Pierre et Marie Curie, 91 Boulevard de l'hôpital, 75634 Paris Cedex 13, France, (jrobert@chups.jussieu.fr)

Abstract

Gentamicin-susceptible methicillin-resistant Staphylococcus aureus (GS-MRSA) strains are replacing gentamicin-resistant MRSA (GR-MRSA) strains. We showed that exposure to other patients harboring GS-MRSA was the major risk factor for GS-MRSA acquisition, and that antimicrobial exposure, especially to β-lactams, was strongly associated with acquisition of GR-MRSA but not GS-MRSA. Gentamicin use was significantly associated with GR-MRSA acquisition in univariate analysis only.

Information

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable